↓ Skip to main content

Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer

Overview of attention for article published in Breast Cancer Research and Treatment, May 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (71st percentile)
  • Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

patent
2 patents

Citations

dimensions_citation
160 Dimensions

Readers on

mendeley
131 Mendeley
Title
Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer
Published in
Breast Cancer Research and Treatment, May 2011
DOI 10.1007/s10549-011-1572-5
Pubmed ID
Authors

E. Razis, M. Bobos, V. Kotoula, A. G. Eleftheraki, H. P. Kalofonos, K. Pavlakis, P. Papakostas, G. Aravantinos, G. Rigakos, I. Efstratiou, K. Petraki, D. Bafaloukos, I. Kostopoulos, D. Pectasides, K. T. Kalogeras, D. Skarlos, G. Fountzilas

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 131 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 2%
Russia 2 2%
United Kingdom 1 <1%
Japan 1 <1%
Poland 1 <1%
Unknown 124 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 29 22%
Student > Ph. D. Student 18 14%
Student > Master 17 13%
Student > Bachelor 13 10%
Other 12 9%
Other 25 19%
Unknown 17 13%
Readers by discipline Count As %
Medicine and Dentistry 36 27%
Biochemistry, Genetics and Molecular Biology 30 23%
Agricultural and Biological Sciences 24 18%
Pharmacology, Toxicology and Pharmaceutical Science 5 4%
Psychology 3 2%
Other 8 6%
Unknown 25 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 June 2016.
All research outputs
#5,629,250
of 25,998,826 outputs
Outputs from Breast Cancer Research and Treatment
#1,063
of 5,117 outputs
Outputs of similar age
#28,615
of 128,157 outputs
Outputs of similar age from Breast Cancer Research and Treatment
#14
of 69 outputs
Altmetric has tracked 25,998,826 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,117 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.4. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 128,157 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 69 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.